An injectable monoclonal antibody that targets the insulin-like growth factor I receptor improved proptosis in more than half of people with chronic thyroid eye disease, according to topline results ...

Discusses Positive Top Line Results From REVEAL-2 Phase III Trial in Chronic Thyroid Eye Disease May 5, 2026 8:00 ...

By Siddhi Mahatole May 5 (Reuters) - Viridian Therapeutics said on Tuesday its experimental thyroid eye disease drug met the ...

THE FOREIGNER EXPERIENCE, a one-night tribute concert at the Sitnik Theatre in Hackettstown, NJ, with proceeds benefiting the ...

Stroke awareness; what doctors want people to know ...

Whereas earlier Phase 3 results disappointed Wall Street, new findings in people with “chronic” disease were viewed by ...

Diplopia, or double vision, can signal serious neurological or ocular disease, making rapid and accurate diagnosis essential. Advances in diagnostic tools, including virtual reality systems and ...

"I also wear a glucose monitor, so I know what exercise does to me [and] to my blood sugar." ...

Tapia, MD, PhD, discusses the results of the ADAPT OCULUS trial, which found promising results for treating patients with ...

UniverSoul Circus is back in Atlanta for the first time since 2024, setting up its Big Top at the former Turner Field Grey Lot.

Toronto Blue Jays player Nathan Lukes is hitting his stride after being treated for vertigo. Despite a rocky start to the 2026 season, Lukes hit two runs during Monday’s game that saw the Blue Jays ...

Call it the Clash of 1976 — not a roster but a diagnosis. A culture realizing it has more than one argument on its hands and ...